Teva Receives FDA Approval For Leukemia Treatment For Injection

– Synribo received provisional approval in 2012 subject to additional clinic trial data. – –  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Food and More...